共 123 条
[1]
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]
Bray F(2005)Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial J Clin Oncol 23 3509-16
[3]
Center MM(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
[4]
Ferlay J(2015)40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study Lancet 385 1026-218
[5]
Ward E(1997)Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403-13
[6]
Forman D(2006)Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer Cancer 107 676-685
[7]
Louvet C(2007)Gemcitabine-based combinations for inoperable pancreatic cancer: have We made real progress? a meta-analysis of 20 phase 3 trials Cancer 110 525-33
[8]
Labianca R(2012)Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? World J Gastroenterol 18 4944-58
[9]
Hammel P(2010)Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the cancer and leukemia group B (CALGB 80303) J Clin Oncol 28 3617-22
[10]
Lledo G(2010)Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: southwest oncology group-directed intergroup trial S0205 J Clin Oncol 28 3605-10